These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35946042)

  • 1. Clinical outcomes of COVID-19 infection in patients with pre-existing cardiovascular disease.
    Kerolos MM; Ruge M; Gill A; Planek MI; Volgman AS; Du-Fay-De-Lavallaz JM; Gomez JMD; Suboc TM; Williams KA; Abusin S
    Am Heart J Plus; 2022 Aug; 20():100189. PubMed ID: 35946042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between pre-existing cardiovascular disease, mortality and cardiovascular outcomes in hospitalised patients with COVID-19.
    Sritharan HP; Bhatia KS; van Gaal W; Kritharides L; Chow CK; Bhindi R
    Front Cardiovasc Med; 2023; 10():1224886. PubMed ID: 37476577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry).
    Pareek M; Singh A; Vadlamani L; Eder M; Pacor J; Park J; Ghazizadeh Z; Heard A; Cruz-Solbes AS; Nikooie R; Gier C; Ahmed ZV; Freeman JV; Meadows J; Smolderen KGE; Lampert R; Velazquez EJ; Ahmad T; Desai NR
    Am J Cardiol; 2021 May; 146():99-106. PubMed ID: 33539857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of cardiac troponin for 60 day mortality and major adverse events in COVID-19 patients.
    Ruge M; Gomez JMD; du Fay de Lavallaz J; Hlepas A; Rahman A; Patel P; Lavani P; Nair GG; Jahan N; Simmons JA; Rao AK; Williams KA; Volgman AS; Marinescu K; Suboc T
    Cardiovasc Pathol; 2021; 55():107374. PubMed ID: 34358679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New-Onset Atrial Fibrillation in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Registry.
    Rosenblatt AG; Ayers CR; Rao A; Howell SJ; Hendren NS; Zadikany RH; Ebinger JE; Daniels JD; Link MS; de Lemos JA; Das SR
    Circ Arrhythm Electrophysiol; 2022 May; 15(5):e010666. PubMed ID: 35475654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality and Major Adverse Cardiovascular Events in Hospitalized Patients With Atrial Fibrillation With COVID-19.
    Wang L; Hoang L; Aten K; Abualfoul M; Canela V; Prathivada S; Vu M; Zhao Y; Sidhu M
    Am J Cardiol; 2023 Feb; 189():41-48. PubMed ID: 36502570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Trends in Guideline-Based Oral Anticoagulant Prescription for Patients With Ischemic Stroke and Atrial Fibrillation in China.
    Gu HQ; Yang X; Wang CJ; Zhao XQ; Wang YL; Liu LP; Meng X; Jiang Y; Li H; Liu C; Xiong YY; Fonarow GC; Wang D; Xian Y; Li ZX; Wang YJ
    JAMA Netw Open; 2021 Jul; 4(7):e2118816. PubMed ID: 34323982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke.
    Buckley BJR; Harrison SL; Hill A; Underhill P; Lane DA; Lip GYH
    Stroke; 2022 May; 53(5):1759-1763. PubMed ID: 35354300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study.
    Prabhakaran D; Singh K; Kondal D; Raspail L; Mohan B; Kato T; Sarrafzadegan N; Talukder SH; Akter S; Amin MR; Goma F; Gomez-Mesa J; Ntusi N; Inofomoh F; Deora S; Philippov E; Svarovskaya A; Konradi A; Puentes A; Ogah OS; Stanetic B; Issa A; Thienemann F; Juzar D; Zaidel E; Sheikh S; Ojji D; Lam CSP; Ge J; Banerjee A; Newby LK; Ribeiro ALP; Gidding S; Pinto F; Perel P; Sliwa K;
    Glob Heart; 2022; 17(1):40. PubMed ID: 35837356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study.
    Noumegni SR; Didier R; Mansourati V; Moigne EL; Mao RL; Hoffmann C; Moreuil C; Tromeur C; Roux PL; Nasr B; Gentric JC; Guegan M; Poulhazan E; Lacut K; Bressollette L; Couturaud F
    Semin Thromb Hemost; 2022 Jun; 48(4):465-480. PubMed ID: 35772402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-existing atrial fibrillation and risk of arterial thromboembolism and death in intensive care unit patients: a population-based cohort study.
    Gamst J; Christiansen CF; Rasmussen BS; Rasmussen LH; Thomsen RW
    Crit Care; 2015 Aug; 19(1):299. PubMed ID: 26286550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score.
    Polovina M; Đikić D; Vlajković A; Vilotijević M; Milinković I; Ašanin M; Ostojić M; Coats AJS; Seferović PM
    Int J Cardiol; 2017 Dec; 249():191-197. PubMed ID: 28986061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Banerjee A; Clementy N; Haguenoer K; Fauchier L; Lip GY
    Am J Med; 2014 Oct; 127(10):972-8. PubMed ID: 24929021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperdynamic left ventricular ejection fraction is associated with higher mortality in COVID-19 patients.
    Rahman A; Ruge M; Hlepas A; Nair G; Gomez J; du Fay de Lavallaz J; Fugar S; Jahan N; Volgman AS; Williams KA; Rao A; Marinescu K; Suboc T
    Am Heart J Plus; 2022 Feb; 14():100134. PubMed ID: 35463197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of thromboembolic risk scores for evaluating in-hospital events of COVID-19 patients.
    Genç Ö; Yildirim A; Genç M; Er F; Alici G; Quisi A; Harbalioğlu H; Allahverdiyev S; Kurt İH
    Biomark Med; 2023 Jan; 17(2):59-72. PubMed ID: 37038968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation incidence, prevalence, predictors, and adverse outcomes in acute coronary syndromes: A pooled analysis of data from 8 million patients.
    Noubiap JJ; Agbaedeng TA; Nyaga UF; Lau DH; Worthley MI; Nicholls SJ; Sanders P
    J Cardiovasc Electrophysiol; 2022 Mar; 33(3):414-422. PubMed ID: 34981859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migraine and risk of cardiovascular diseases: Danish population based matched cohort study.
    Adelborg K; Szépligeti SK; Holland-Bill L; Ehrenstein V; Horváth-Puhó E; Henderson VW; Sørensen HT
    BMJ; 2018 Jan; 360():k96. PubMed ID: 29386181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cancer and cardiovascular disease on in-hospital outcomes of COVID-19 patients: results from the american heart association COVID-19 cardiovascular disease registry.
    Tehrani DM; Wang X; Rafique AM; Hayek SS; Herrmann J; Neilan TG; Desai P; Morgans A; Lopez-Mattei J; Parikh RV; Yang EH
    Cardiooncology; 2021 Aug; 7(1):28. PubMed ID: 34372948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for mortality among hospitalized COVID-19 patients in Northern Ethiopia: A retrospective analysis.
    Abebe HT; Mulugeta A; Berhe Y; Berhane K; Siraj A; Siraj D; Aregawi M; Fseha B; Mohamedniguss Ebrahim M; Hintsa S; Gebre H; Mohammed AH; Godefay H
    PLoS One; 2022; 17(8):e0271124. PubMed ID: 35951497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.